MetLife Investment Management’s Nuvectis Pharma NVCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,970	Closed	-$63.4K	–	2952
2023 Q2	$63.4K	Buy	+3,970	New	+$63.4K	﹤0.01%	2874